Crocs stock (NASDAQ: CROX) has declined by over 30% in the past six months, presenting what we believe to be an attractive value opportunity for investors. The recent downturn isn't solely due to ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. During ...

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At ...

Fintel reports that on August 8, 2025, Stifel downgraded their outlook for Crocs (NasdaqGS:CROX) from Buy to Hold. Analyst Price Forecast Suggests 70.20% Upside As of August 6, 2025, the average ...

Footwear company Crocs (NASDAQ:CROX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.4% year on year to $1.15 billion. On the other hand, next quarter’s revenue guidance of $956 ...

Shares of footwear company Crocs (NASDAQ:CROX) jumped 0.3% in the morning session after the company announced the appointment of a new Chief Financial Officer and reaffirmed its third-quarter ...

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their ...